HIMS

Hims Hers Health Inc

HIMS, USA

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.

https://www.hims.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HIMS
stock
HIMS

Hims & Hers Expands Weight-Management Program to the United Kingdom Finviz

Read more →
HIMS
stock
HIMS

Regulatory Proposal Sparks Volatility for Hims & Hers Shares Ad-hoc-news.de

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$46

Analyst Picks

Strong Buy

4

Buy

1

Hold

6

Sell

1

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

75.02

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

15.96

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

2.72 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.71 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

15.26 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

2.84

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 89.08% of the total shares of Hims Hers Health Inc

1.

BlackRock Inc

(10.9501%)

since

2025/06/30

2.

Vanguard Group Inc

(8.2617%)

since

2025/06/30

3.

Capital World Investors

(8.2114%)

since

2025/06/30

4.

American Funds Growth Fund of Amer A

(5.7539%)

since

2025/06/30

5.

Capital Group Growth Fnd of Amer Comp

(5.7539%)

since

2025/06/30

6.

Farallon Capital Management, L.L.C.

(3.634%)

since

2025/06/30

7.

Goldman Sachs Group Inc

(3.6116%)

since

2025/06/30

8.

State Street Corp

(3.1151%)

since

2025/06/30

9.

Renaissance Technologies Corp

(3.0393%)

since

2025/06/30

10.

iShares Core S&P Mid-Cap ETF

(2.8236%)

since

2025/08/31

11.

Morgan Stanley - Brokerage Accounts

(2.4463%)

since

2025/06/30

12.

Vanguard Total Stock Mkt Idx Inv

(2.3968%)

since

2025/07/31

13.

JPMorgan Large Cap Growth I

(2.1964%)

since

2025/07/31

14.

Geode Capital Management, LLC

(2.0999%)

since

2025/06/30

15.

iShares Russell 2000 ETF

(2.0346%)

since

2025/08/31

16.

Vanguard Small Cap Index

(1.8515%)

since

2025/07/31

17.

SRS Investment Management, LLC

(1.7698%)

since

2025/06/30

18.

American Funds IS® Growth 1

(1.2601%)

since

2025/06/30

19.

Capital Group Growth Composite

(1.2601%)

since

2025/06/30

20.

JPMorgan Chase & Co

(1.2125%)

since

2025/06/30

21.

Amvescap Plc.

(1.1293%)

since

2025/06/30

22.

UBS Group AG

(1.1286%)

since

2025/06/30

23.

Northern Trust Corp

(1.0543%)

since

2025/06/30

24.

Vanguard Small Cap Growth Index Inv

(1.0435%)

since

2025/07/31

25.

Dimensional Fund Advisors, Inc.

(0.9741%)

since

2025/06/30

26.

Vanguard Institutional Extnd Mkt Idx Tr

(0.932%)

since

2025/07/31

27.

Fidelity Small Cap Index

(0.8462%)

since

2025/06/30

28.

D. E. Shaw & Co LP

(0.8349%)

since

2025/06/30

29.

American Funds SMALLCAP World A

(0.7862%)

since

2025/06/30

30.

CLEAR STREET LLC.

(0.7418%)

since

2025/06/30

31.

iShares Russell 2000 Growth ETF

(0.7413%)

since

2025/08/31

32.

Charles Schwab Investment Management Inc

(0.7122%)

since

2025/06/30

33.

Wellington Management Company LLP

(0.6981%)

since

2025/06/30

34.

NORGES BANK

(0.6964%)

since

2025/06/30

35.

SPDR® S&P MIDCAP 400 ETF Trust

(0.6645%)

since

2025/07/31

36.

Invesco S&P MidCap Quality ETF

(0.6431%)

since

2025/08/29

37.

iShares S&P Mid-Cap 400 Growth ETF

(0.4943%)

since

2025/08/31

38.

Fidelity Extended Market Index

(0.4679%)

since

2025/07/31

39.

Schwab US Small-Cap ETFâ„¢

(0.4115%)

since

2025/08/30

40.

BIT Global Technology Leaders R-I

(0.4022%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.0517

Latest Release

Date

2025-09-30

EPS Actual

0.06

EPS Estimate

0.1

EPS Difference

-0.04

Surprise Percent

-40%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.3)
GARP
Not Attractive for GARP(3)
Growth
Moderate Growth(3.5)
Momentum
Strong Momentum(7)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Overpriced(2.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.